Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Caux

Showing results (41-50 of 142) with videos related to

Pageof 15
Sort By:
The Journal of Experimental Medicine|September 4, 2003
The inducible CXCR3 ligands control plasmacytoid dendritic cell responsiveness to the constitutive chemokine stromal cell-derived factor 1 (SDF-1)/CXCL12Béatrice Vanbervliet, Nathalie Bendriss-Vermare, Catherine Massacrier, et al.
Cancers|April 30, 2021
Recruitment and Expansion of Tregs Cells in the Tumor Environment-How to Target Them?Justine Cinier, Margaux Hubert, Laurie Besson, et al.
Oncoimmunology|November 14, 2025
Dendritic cells: the central partner for cancer immunityLéo Laoubi, Elisa Gobbini, Pierre Duplouye, et al.
Frontiers in Immunology|October 17, 2019
Neutrophil Heterogeneity in Cancer: From Biology to TherapiesPacôme Lecot, Matthieu Sarabi, Manuela Pereira Abrantes, et al.
Transplantation|January 26, 2002
Regulation of dendritic cell recruitment by chemokinesChristophe Caux, Béatrice Vanbervliet, Catherine Massacrier, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 28, 2007
Cell proliferation and survival induced by Toll-like receptors is antagonized by type I IFNsUzma A Hasan, Christophe Caux, Ivan Perrot, et al.
Journal for Immunotherapy of Cancer|February 28, 2020
Repurposing infectious disease vaccines for intratumoral immunotherapyIgnacio Melero, Maria Gato, Tala Shekarian, et al.
Oncoimmunology|March 28, 2017
Description of the immune microenvironment of chondrosarcoma and contribution to progressionFrançois A Simard, Iseulys Richert, Alexandra Vandermoeten, et al.
Oncotarget|June 22, 2018
CD73 expression and clinical significance in human metastatic melanomaInês Monteiro, Selena Vigano, Mohamed Faouzi, et al.
The Journal of Biological Chemistry|September 8, 2005
Recognition of double-stranded RNA by human toll-like receptor 3 and downstream receptor signaling requires multimerization and an acidic pHOdette de Bouteiller, Estelle Merck, Uzma A Hasan, et al.
Pageof 15

Showing results (41-50 of 142) with videos related to

Sort By:
Pageof 15
The Journal of Experimental Medicine|September 4, 2003
The inducible CXCR3 ligands control plasmacytoid dendritic cell responsiveness to the constitutive chemokine stromal cell-derived factor 1 (SDF-1)/CXCL12Béatrice Vanbervliet, Nathalie Bendriss-Vermare, Catherine Massacrier, et al.
Cancers|April 30, 2021
Recruitment and Expansion of Tregs Cells in the Tumor Environment-How to Target Them?Justine Cinier, Margaux Hubert, Laurie Besson, et al.
Oncoimmunology|November 14, 2025
Dendritic cells: the central partner for cancer immunityLéo Laoubi, Elisa Gobbini, Pierre Duplouye, et al.
Frontiers in Immunology|October 17, 2019
Neutrophil Heterogeneity in Cancer: From Biology to TherapiesPacôme Lecot, Matthieu Sarabi, Manuela Pereira Abrantes, et al.
Transplantation|January 26, 2002
Regulation of dendritic cell recruitment by chemokinesChristophe Caux, Béatrice Vanbervliet, Catherine Massacrier, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 28, 2007
Cell proliferation and survival induced by Toll-like receptors is antagonized by type I IFNsUzma A Hasan, Christophe Caux, Ivan Perrot, et al.
Journal for Immunotherapy of Cancer|February 28, 2020
Repurposing infectious disease vaccines for intratumoral immunotherapyIgnacio Melero, Maria Gato, Tala Shekarian, et al.
Oncoimmunology|March 28, 2017
Description of the immune microenvironment of chondrosarcoma and contribution to progressionFrançois A Simard, Iseulys Richert, Alexandra Vandermoeten, et al.
Oncotarget|June 22, 2018
CD73 expression and clinical significance in human metastatic melanomaInês Monteiro, Selena Vigano, Mohamed Faouzi, et al.
The Journal of Biological Chemistry|September 8, 2005
Recognition of double-stranded RNA by human toll-like receptor 3 and downstream receptor signaling requires multimerization and an acidic pHOdette de Bouteiller, Estelle Merck, Uzma A Hasan, et al.
Pageof 15